Compared with transdermal treatment, the use of oral hormone replacement therapy (HRT) is associated with a greater risk of venous thromboembolism (VTE), according to a retrospective database study.

Venous thromboembolism (VTE) is common in patients with cancer and can increase the risk of dying, as well as interfering with treatment and increasing the cost of treatment. New findings suggest that ...

Patients with RA have a higher risk of blood clots and serious infections with baricitinib vs older biologics, but not heart disease or cancer, according to two safety trials.

Beefed up label warning now appears likely, though events still rare ...

—Venous thromboembolism (VTE) can pose a significant danger to cancer patients, but little is known about the specific risk of VTE in diffuse large B-cell lymphoma (DLBCL) versus follicular lymphoma ...

Compared with nonusers, those on a GLP-1 receptor agonist had fewer thromboembolic events and higher survival.

thrombus, blood clot, thrombosis The adjusted rate of venous thromboembolism was 2.3-fold higher during the first 30 days after gout flare compared with baseline. Venous thromboembolism (VTE) risk ...

TAMPA, Fla. -- As lines of therapy increased for recurrent ovarian cancer, so did the risk of venous thromboembolism (VTE), a retrospective study showed. Almost 80% of VTEs occurred in patients who ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among veterans hospitalized at Veterans Affairs ...

The VTE-BLEED score identifies 6 differently weighted variables (active cancer [2 points], men with uncontrolled hypertension [1 point], anemia [1.5 points], history of bleeding [1.5 points], age ³60 ...